AstraZeneca PLC is 172.4x more valuable than Nuvation Bio Inc. by market capitalization ($286.27 B vs $1.66 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NUVB | AZN |
|---|---|---|
| Market cap | $1.66 B | $286.27 B |
| US-listed rank | #2254 | #47 |
| Revenue (latest FY) | $62.90M | - |
| Net income (latest FY) | -$204.63M | - |
| Net margin | -325.3% | - |
| SEC filings | 379 | 1,004 |
AstraZeneca PLC is 172.4x more valuable than Nuvation Bio Inc. by market capitalization ($286.27 B vs $1.66 B).
Full pages: Nuvation Bio Inc. and AstraZeneca PLC, or browse the full rankings.